Header
Dataemia
Menu
Search for
Switch skin
Latest News
Cardiology
Dentistry
Surgery/Cosmetic
Neurology
AI/ML
Pharma / Biotech
Pediatrics
Biology
Gastroenterology
COVID-19 Live Stats
CPHQ
Informatics
Research
Privacy Policy
Disclaimer
Contact US
Search for
Switch skin
Sidebar
Random Article
LinkedIn
Twitter
Facebook
Header
unresectable
Gastroenterology
December 21, 2022
122
Trifluridine-tipiracil plus bevacizumab ‘feasible alternative’ for unresectable CRC
Gastroenterology
December 19, 2022
144
Safety and efficacy analysis of chemoradiotherapy/radiotherapy combined with nimotuzumab for treating unresectable oesophageal squamous cell carcinoma in elderly patients: a retrospective analysis | BMC Gastroenterology
Gastroenterology
December 7, 2022
144
Efficacy of a novel self-expandable metal stent with dumbbell-shaped flare ends for distal biliary obstruction due to unresectable pancreatic cancer
Surgery/Cosmetic
September 26, 2022
151
Tyrosine kinase inhibitors versus radiation therapy in unresectable dermatofibrosarcoma protuberans (DFSP): A narrative systematic review
Latest News
September 11, 2022
158
Merck and Eisai Present Results From Phase 3 LEAP-002 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Versus LENVIMA Monotherapy in Patients With Unresectable Hepatocellular Carcinoma
Latest News
September 10, 2022
145
BeiGene Announces Data Presentations at ESMO 2022 Including Late-Breaking Oral Presentation for Tislelizumab in First-Line Unresectable Hepatocellular Cancer
Surgery/Cosmetic
June 6, 2022
156
Radiation Segmentectomy Efficacious for Unresectable Liver Cancer
Latest News
May 28, 2022
184
U.S. Food and Drug Administration Approves Two Opdivo® (nivolumab)-Based Regimens as First-Line Treatments for Unresectable Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Gastroenterology
March 30, 2022
155
CRC patients with unresectable liver metastases may benefit from living-donor LT
Latest News
March 18, 2022
170
U.S. Food and Drug Administration Approves First LAG-3-Blocking Antibody Combination, Opdualag™ (nivolumab and relatlimab-rmbw), as Treatment for Patients with Unresectable or Metastatic Melanoma
Latest News
December 3, 2018
137
Everolimus, lutetium-177 DOTATATE and sunitinib for advanced, unresectable or metastatic neuroendocrine tumours with disease progression: A systematic review and cost-effectiveness analysis
Gastroenterology
November 9, 2018
139
TARE-Y90 safe, effective for unresectable pediatric liver tumors
Dermatology
September 13, 2018
135
How to MEK the best of uveal melanoma: A systematic review on the efficacy and safety of MEK inhibitors in metastatic or unresectable uveal melanoma.
Gastroenterology
September 5, 2018
141
Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis
Gastroenterology
August 16, 2018
138
FDA OKs First-Line Tx for Unresectable Liver Cancer
Gastroenterology
August 16, 2018
142
FDA approves Lenvima for unresectable hepatocellular carcinoma
Back to top button
Close
Search for
Close
Search for
